Guillermina Barril^1,2*, Alicia Cabrera², Paloma Lopez Alvarado², Patricia Ochoa², Graciela Alvarez² and Angel Nogueira^3,2

¹Fundación Investigaciones Biomédicas, Spain
²Department of Nephrology Hospital Universitario de la Princesa, Madrid, Spain
³Avericum Las Palmas de Gran Canaria, Spain

*Corresponding Author: Guillermina Barril, Fundación Investigaciones Biomédicas, Spain.

Received: June 19, 2025; Published: July 14, 2025

Abstract

Objective:This study aimed to explore the usefulness muscle ultrasound as tool for evaluation muscle parameters in CKD patients.

Methods: Ultrasound muscle evaluation of the right rectus femoris , hand grip strenght, biochemical parameters, right calf circumference and vectorial bioelectrical impedance analysis measurement of the right lower limb were performed in CKD patients. The correlations between the changes in the corresponding ultrasound and bioelectrical impedance analysis variables were analyzed. Results: Have been evaluated a total of 78 patients, (68 in CKD stage G5, G4, G3b non in dialysis and 10 on peritoneal dialysis (PD)), with mean age of 71.54 ± 11.76 years, 59% were male and 48% Diabetes Mellitus. Compared to advanced CKD patients , the measurements of cross-sectional area and axes didn´t find significant difference between CKD and DP. In relation with muscle mass ultrasound parameters in CKD patients the possible factor can influence favorizing better values were: Exercice, lower age, and good hand grip strenght as phase angle and intracellular water adecuate can influence a good muscle mass parameters.

Conclusions

• CKD results in lower values in the eco-muscular assessment than healthy people in both CKD and DP.
• The transverse and longitudinal diameters and muscle area are smaller than those described in the healthy population.
• Having performed physical exercise conditions better parameters in the muscle ultrasound
• Muscle ultrasound appears as an emerging, economical, easy tool that does not provide ionizing radiation.
• It´s necessary more study in order stablish the normal values according age groups

Keywords: Ultrasound,CKD, DP

References

1. Foreman KJ., et al. “Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories”. Lancet10159 (2018): 2052-2090.
2. Jha V., et al. “Chronic kidney disease: global dimension and perspectives”. Lancet 382 (2013): 260-272.
3. Go AS., et al. “Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization”. The New England Journal of Medicine 351 (2004): 1296-1305.
4. Fouque D., et al. “A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney Disease”. Kidney International 73 (2008): 391-398.
5. Nijholt W., et al. “The reliability and validity of ultrasound to quantifly muscle in older adults: A systematic review”. Journal of Cachexia Sarcopenia Muscle 8 (2017): 702-712.
6. Correa-de-Araujo R., et al. “The need for standardized assessment of muscle quality in skeletal muscle function deficit and other aging-related muscle dysfunctions: a symposium report”. Frontiers Physiology 8 (2017):
7. Cruz-Jentoft AJ., et al. “European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People”. Age Ageing4 (2010): 412-423.
8. Cruz-Jentoft AJ., et al. “Sarcopenia: revised European consensus on definition and diagnosis”. Age Ageing 48 (2019): 16-31.  
9. Wang JC., et al. “Ultrasound Imaging for the Diagnosis and Evaluation of Sarcopenia: An Umbrella Review”. Life 1 (2021): 9.
10. Lam FMH., et al. “Cumulative and Incremental Value of Sarcopenia Components on Predicting Adverse Outcomes”. Journal of the American Medical Directors Association 21 (2020): 1481-1489.
11. Marcell TJ. “Sarcopenia: causes, consequences, and preventions”. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences 10 (2003): M911-6.
12. Battaglia Y., et al. “Ultrasonography of Quadriceps Femoris Muscle and Subcutaneous Fat Tissue and Body Composition by BIVA in Chronic Dialysis Patients”. Nutrients5 (2020): 1388.
13. Marcelli D., et al. “Physical methods for evaluating the nutrition status of hemodialysis patients”. Journal of Nephrology 28 (2015): 523-530.
14. Battaglia Y., et al. “Ultrasonography of Quadriceps Femoris Muscle and Subcutaneous Fat Tissue and Body Composition by BIVA in Chronic Dialysis Patients”. Nutrients 12 (2020):
15. Furstenberg A and Davenport A. “Comparison of multifrequency bio- electrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient hemodialysis patients”. American Journal of Kidney Diseases 57 (2011): 123-129.
16. Berger J., et al. “Rectus femoris (RF) ultrasound for the assessment of muscle mass in older people”. Archives of Gerontology and Geriatrics 1 (2015):33-38.v[[
17. Abe T., et al. “Site-specific thigh muscle loss as an independent phenomenon for age-related muscle loss in middle-aged and older men and women”. Age (Omaha)3 (2014): 1353-1358.
18. Hammond K., et al. “Validity and reliability of rectus femoris ultrasound measurements: Comparison of curved-array and linear-array transducers”. Journal of Rehabilitation Research and Development (JRRD) 7 (2014): 1155-1164.
19. Smith S and Madden AM. “Body composition and functional assessment of nutritional status in adults: A narrative review of imaging, impedance, strength and functional techniques”. Journal of Human Nutrition and Dietetics 29 (2016): 714-732.

20.   Douglas W Gould., et al. “Ultrasound assessment of muscle mass in response to exercise training in chronic kidney disease: a comparison with MRI”. Journal of Cachexia, Sarcopenia and Muscle 10 (2019): 748-755.

21.   Kramer CS., et al. “The Association between Malnutrition and Physical Performance in Older Adults: A Systematic Review and Meta-Analysis of Observational Studies”. Current Developments in Nutrition 6.4 (2022): nzac007.

22.   Hanna RM., et al. “A Practical Approach to Nutrition, Protein-Energy Wasting, Sarcopenia, and Cachexia in Patients with Chronic Kidney Disease”. Blood Purifier 49.1-2 (2020): 202-211.

23. Csaba P Kovesdy., et al. “Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease”. The American Journal of Clinical Nutrition2 (2009): 407-414.
24. Harada K., et al. “Impact of skeletal muscle mass on long-term adverse cardiovascular outcomes in patients with chronic kidney disease”. The American Journal of Cardiology 119 (2017): 1275-1280.
25. Hyun YY., et al. “Nutritional Status in Adults with Predialysis Chronic Kidney Disease: KNOW-CKD Study”. Journal of Korean Medical Science 2 (2017): 257-263.
26. Ruperto M and Barril G. “Clinical Significance of Nutritional Status, Inflammation, and Body Composition in Elderly Hemodialysis Patients-A Case-Control Study”. Nutrients24 (2023): 5036.
27. G Barril., et al. “Acta Scientific Nutritional Health 1 (2022): 19-27.
28. Pereira RA., et al. “Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality”. Nephrology Dialysis Transplantation 30 (2015): 1718-1725.
29. Nijholt W., et al. “The reliability and validity of ultrasound to quantify muscles in older adults: a systematic review”. Journal of Cachexia Sarcopenia Muscle 8 (2017): 702-712.
30. Visser M., et al. “Muscle mass, muscle strength, and muscle fat infltration as predictors of incident mobility limitations in well-functioning older persons”. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences 3 (2005): 324-333.
31. Malmstrom TK., et al. “SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes”. Journal Cachexia Sarcopenia Muscle 7 (2016): 28-36.
32. Sabatino A., et al. “Sarcopenia in chronic kidney disease: what have we learned so far?” Journal of Nephrology 34 (2021): 1347-1372.
33. Mar Ruperto., et al. “A clinical approach to the nutritional care process in protein energy wasting hemodialysis patients”. Nutrición Hospitalaria 4 (2007): 738-750.
34. Zhao R., et al. “Evaluation of Appendicular Muscle Mass in Sarcopenia in Older Adults Using Ultrasonography: A Systematic Review and Meta-Analysis”. Gerontology 10 (2022): 1174-1198.
35. Wang XH., et al. “Pathophysiological mechanisms leading to muscle loss in chronic kidney disease”. Nature Reviews Nephrology 18 (2022): 138-152.
36. Kruse NT., et al. “Association of skeletal muscle mass, kidney disease and mortality in older men and women: The cardiovascular health study”. Aging 12 (2020): 21023-21036.
37. Cheng KY., et al. “Diagnosis of sarcopenia by evaluating skeletal muscle mass by adjusted bioimpedance analysis validated with dual-energy X-ray absorptiometry”. Journal Cachexia Sarcopenia Muscle6 (2021): 2163-2173.
38. Deger SM., et al. “Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients”. JCI Insight 2 (2017):
39. García-García C., et al. “Rectus Femoris Muscle and Phase Angle as Prognostic Factor for 12-Month Mortality in a Longitudinal Cohort of Patients with Cancer (AnyVida Trial)”. Nutrient3 (2023): 522.
40. Strasser EM., et al. “Association between ultrasound measurements of muscle thickness, pennation angle, echogenicity and skeletal muscle strength in the elderly”. AGE 35 (2013): 2377-2388.
41. Zhu S., et al. “The correlation of muscle thickness and pennation angle assessed by ultrasound with sarcopenia in elderly Chinese community dwellers”. Clinical Interventions in Aging 14 (2019): 987-996.
42. Almeida JMG., et al. “Protocol for a prospective cohort study on the feasibility of application of nutritional ultrasound in the diagnosis and follow-up of patients with nutritional risk at hospital discharge: Study on body composition and function (DRECO)”. BMJ Open 13 (2023):
43. Fernández-Jiménez R., et al. “Ultrasound Muscle Evaluation for Predicting the Prognosis of Patients with Head and Neck Cancer: A Large-Scale and Multicenter Prospective Study”. Nutrients3 (2024): 387.
44. Scott JM., et al. “Panoramic ultrasound: a novel and valid tool for monitoring change in muscle mass”. Journal of Cachexia Sarcopenia Muscle 8 (2017): 475-481.
45. Ishida H., et al. “Influence of the ultrasound transducer tilt on muscle thickness and echo intensity of the rectus femoris muscle of healthy subjects”. The Journal of Physical Therapy Science 29 (2017): 2190-2193.
46. Tomko PM., et al. “Reliability and differences in quadriceps femoris muscle morphology using ultrasonography: the effects of body position and rest time”. Ultrasound 26 (2018): 214-221.
47. Acevedo LM., et al. “Muscle plasticity is influenced by renal function and caloric intake through the FGF23-vitamin D axis”. American Journal of Physiology-Cell Physiology 324 (2023): C14-C28.
48. Tanaka M., et al. “Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1”. Scientific Reports 6 (2016):
49. Ziolkowski SL., et al. “Relative sarcopenia and mortality and the modifying effects of chronic kidney disease and adiposity”. Journal of Cachexia Sarcopenia Muscle 10 (2019): 338-346.
50. Enoki Y., et al. “Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1”. Scientific Report 6 (2016):
51. Ziolkowski SL., et al. “Relative sarcopenia and mortality and the modifying effects of chronic kidney disease and adiposity”.Journal of Cachexia Sarcopenia Muscle 10 (2019): 338-346.
52. Yu MD., et al. “Relationship between chronic kidney disease and sarcopenia”. Scientific Report 11 (2021):
53. Mar Ruperto., et al. “A clinical approach to the nutritional care process in protein energy wasting hemodialysis patients”. Nutrición Hospitalaria 4 (2018): 738-750.
54. Stenvinkel P., et al. “Muscle wasting in end-stage renal disease promulgates premature death: Established, emerging and potential novel treatment strategies”. Nephrology Dialysis Transplantation 31 (2016): 1070-1077.
55. Wang XH and Mitch WE. “Mechanisms of muscle wasting in chronic kidney disease”. Nature Reviews Nephrology 10 (2014): 504-516.
56. Wilkinson TJ., et al. “Quality over quantity? Association of skeletal muscle myosteatosis and myofbrosis on physical function in chronic kidney disease”. Nephrology Dialysis Transplantation 8 (2019): 1344-1353.
57. Carrero JJ., et al. “Muscle Atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients”. Clinical Nutrition 27 (2008): 557-564.
58. Schardong J., et al. “Muscle Atrophy in Chronic Kidney Disease”. Advances in Experimental Medicine and Biology 1088 (2018): 393-412.
59. Momb BA., et al. “Iron Supplementation Improves Skeletal Muscle Contractile Properties in Mice with CKD”. Kidney360 3 (2022): 843-858.
60. Hung KC., et al. “The Potential Influence of Uremic Toxins on the Homeostasis of Bones and Muscles in Chronic Kidney Disease”. Biomedicines 11 (2023):
61. Andres-Hernando A., et al. “Phosphate depletion in insulin-insensitive skeletal muscle drives AMPD activation and sarcopenia in chronic kidney disease”. iScience 26 (2023):
62. Sabatino A., et al. “Noninvasive evaluation of muscle mass by ultrasonography of quadriceps femoris muscle in End-Stage Renal Disease patients on hemodialysis”. Clinical Nutrition (2018):
63. Deger SM., et al. “Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients”. JCI Insight 2 (2017):
64. Elder M., et al. “Chronic kidney disease-related sarcopenia as a prognostic indicator in elderly haemodialysis patients”. BMC Nephrology 24 (2023):
65. Junzhen Wu., et al. “Enhanced echo intensity of skeletal muscle is associated with poor physical function in hemodialysis patients: a cross-sectional study”. BMC Nephrology (2022) 23:186.
66. Czaya B., et al. “Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling”. eLife 11 (2002):
67. Avesani CM., et al. “Muscle fat infiltration in chronic kidney disease: A marker related to muscle quality, muscle strength and sarcopenia”. Journal of Nephrology 36 (2023): 895-910.
68. Worsley PR., et al. “Validity of measuring distal vastus medialis muscle using rehabilitative ultrasound imaging versus magnetic resonance imaging”. Manual Therapy 19 (2014): 259-263.
69. Douglas W Gould., et al. “Ultrasound assessment of muscle mass in response to exercise training in chronic kidney disease: a comparison with MRI”. Journal of Cachexia, Sarcopenia and Muscle 10 (2019): 748-755.
70. Sabatino A., et al. “Noninvasive evaluation of muscle mass by ultrasonography of quadriceps femoris muscle in End-Stage Renal Disease patients on hemodialysis”. Clinical Nutrition 38 (2019): 1232-1239.
71. Franchi MV., et al. “Muscle thickness correlates to muscle cross-sectional area in the assessment of strength training-induced hypertrophy”. Scandinavian Journal of Medicine and Science in Sports 28 (2018): 846-853.

Citation

Citation: Guillermina Barril., et al. “Muscle Ultrasound as an Emergy Tool for Assessment of Quantity and Quality of Muscle in Chronic Kidney Disease (CKD) Patients".Acta Scientific Nutritional Health 9.8 (2025): 23-36.

Copyright

Copyright: © 2025 Guillermina Barril., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.